Clinical Trial Update: Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC [NA]

View source ↗

Summary

A completed clinical trial evaluating liquid biopsy genotyping using the Oncomine Precision Assay GX in advanced Non-Small Cell Lung Cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Non-Small Cell Lung Cancer | NA | Status: COMPLETED